Aardvark Therapeutics, Inc. Common Stock (AARD)
NASDAQ·Healthcare·Biotechnology
$3.89
+6.87%
Mkt Cap $120.42M
Analyst Ratings
Buy
5
Hold
3
Sell
0
Price Target (7 analysts)
$22.75
Range $3.00 – $47.00
Implied Upside
+484.8%
Consensus $22.75 vs current $3.89